These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 29582252

  • 1. Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study.
    Suda M, Ohde S, Tsuda T, Kishimoto M, Okada M.
    Clin Rheumatol; 2018 Aug; 37(8):2027-2034. PubMed ID: 29582252
    [Abstract] [Full Text] [Related]

  • 2. Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
    Fortunet C, Pers YM, Lambert J, Godfrin-Valnet M, Constant E, Devilliers H, Gaudin P, Jorgensen C, Prades BP, Wendling D, Maillefert JF.
    Rheumatology (Oxford); 2015 Apr; 54(4):672-7. PubMed ID: 25246640
    [Abstract] [Full Text] [Related]

  • 3. The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy.
    Panthakalam S, Bhatnagar D, Klimiuk P.
    Scott Med J; 2004 Nov; 49(4):139-41. PubMed ID: 15648707
    [Abstract] [Full Text] [Related]

  • 4. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.
    Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE.
    Am J Med; 1994 Feb; 96(2):115-23. PubMed ID: 8109596
    [Abstract] [Full Text] [Related]

  • 5. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
    Kawashima H, Kagami SI, Kashiwakuma D, Takahashi K, Yokota M, Furuta S, Iwamoto I.
    Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943
    [Abstract] [Full Text] [Related]

  • 6. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS, van Vollenhoven R, Kavanaugh A, Strand V, Vencovsky J, Schiff M, Landewé R, Haraoui B, Arendt C, Mountian I, Carter D, van der Heijde D.
    Arthritis Res Ther; 2015 Sep 10; 17(1):245. PubMed ID: 26353833
    [Abstract] [Full Text] [Related]

  • 7. [Corticosteroid therapy and aseptic bone necrosis in patients with rheumatoid arthritis].
    Tsurko VV, Ivanova MM, Tokmachev IuK.
    Ter Arkh; 1995 Sep 10; 67(7):71-4. PubMed ID: 7482313
    [Abstract] [Full Text] [Related]

  • 8. Eficiency of different doses of rituximab in rheumatoid arthritis.
    Mena-Vázquez N, Manrique-Arija S, Ureña-Garnica I, Romero-Barco CM, Jiménez-Núñez FG, Coret V, Irigoyen-Oyarzábal MV, Fernández-Nebro A.
    Reumatol Clin; 2016 Sep 10; 12(3):139-45. PubMed ID: 26458761
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic obstructive pulmonary disease with corticosteroids. Comparison of daily vs alternate-day therapy.
    Blair GP, Light RW.
    Chest; 1984 Oct 10; 86(4):524-8. PubMed ID: 6383740
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate.
    Lee WS, Lee SI, Lee MS, Kim SI, Lee SS, Yoo WH.
    Korean J Intern Med; 2016 Jul 10; 31(4):779-87. PubMed ID: 26961485
    [Abstract] [Full Text] [Related]

  • 11. Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.
    Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Van der Elst K, Meyfroidt S, Westhovens R, CareRA study group.
    Arthritis Res Ther; 2015 Apr 09; 17(1):97. PubMed ID: 25889222
    [Abstract] [Full Text] [Related]

  • 12. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW, Weinblatt ME, Keystone EC, Kremer JM, Martin RW, Schiff MH, Whitmore JB, White BW.
    J Rheumatol; 2006 May 09; 33(5):854-61. PubMed ID: 16541481
    [Abstract] [Full Text] [Related]

  • 13. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK.
    J Rheumatol; 2003 Dec 09; 30(12):2563-71. PubMed ID: 14719195
    [Abstract] [Full Text] [Related]

  • 14. The role of methotrexate and low-dose prednisolone on adiponectine levels and insulin resistance in patients with rheumatoid arthritis naïve to disease-modifying antirheumatic drugs.
    Yaşar Bilge NŞ, Kaşifoğlu N, Kaşifoğlu T, Şahin F, Gönüllü E, Korkmaz C.
    Int J Rheum Dis; 2016 Jul 09; 19(7):665-71. PubMed ID: 26222244
    [Abstract] [Full Text] [Related]

  • 15. Undetectable Mannose Binding Lectin and Corticosteroids Increase Serious Infection Risk in Rheumatoid Arthritis.
    Carroll GJ, Makin K, Garnsey M, Bulsara M, Carroll BV, Curtin SM, Allan EM, McLean-Tooke A, Bundell C, Kemp ML, Deshpande P, Ihdayhid D, Coleman S, Easter T, Triplett J, Disteldorf T, Marsden CH, Lucas M.
    J Allergy Clin Immunol Pract; 2017 Jul 09; 5(6):1609-1616. PubMed ID: 28634103
    [Abstract] [Full Text] [Related]

  • 16. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM).
    Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, Iikuni N, Nawata M, Amano K, Shinozaki M, Takeuchi T.
    Mod Rheumatol; 2007 Jul 09; 17(1):28-32. PubMed ID: 17278019
    [Abstract] [Full Text] [Related]

  • 17. Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis.
    Paulus HE, Di Primeo D, Sanda M, Lynch JM, Schwartz BA, Sharp JT, Genant HK, Weissman BN.
    J Rheumatol; 2000 Jul 09; 27(7):1632-7. PubMed ID: 10914843
    [Abstract] [Full Text] [Related]

  • 18. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
    Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli FR, Spadaro A, Valesini G.
    Rheumatology (Oxford); 2011 Jun 09; 50(6):1148-52. PubMed ID: 21278072
    [Abstract] [Full Text] [Related]

  • 19. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L.
    J Rheumatol; 2000 Aug 09; 27(8):2018-24. PubMed ID: 10955346
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan.
    Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Sano Y, Yaguramaki H, Yamanaka H.
    J Rheumatol; 2014 Jan 09; 41(1):15-23. PubMed ID: 24187110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.